SCHEMBL11967916

SCHEMBL11967916

CCc1cc(Nc2cc(=O)n(CCCCCN3CCN(C4=CC(=O)C(C(=O)O)C(C5CC5)=N4)CC3)c(=O)[nH]2)ccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6903769 0.80 — —
SCHEMBL3471013 0.78 — —
SCHEMBL6904574 0.78 — —
SCHEMBL6902934 0.77 — —
SCHEMBL6904980 0.77 — —
SCHEMBL6899572 0.77 — —
SCHEMBL7041582 0.77 — —
SCHEMBL7111268 0.77 — —
SCHEMBL4743074 0.76 — —
SCHEMBL4739730 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401829-B1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX INC (US) 2012-08-22 — — EP claimed
Send feedback